THE SCALABLE SOLUTION TO STEM CELL EXPANSION
Cytomatrix is a Melbourne based stem cell therapeutics company, that offers a scalable solution to bone marrow transplantation utilising 3D expanded allogeneic cord blood
Patients diagnosed with leukaemia and other indications require treatments such as bone marrow or cord blood transplants. Cord blood, from the umbilical cord and placenta, contains “Haemopoietic stem cells” (HSCs) which once transferred to the patient produce further blood cells.
“The critical advantages of the new technology are: culture in 3 dimensions, scalability and incorporation of world leading technologies.”
Cytomatrix will be first to market with commercial 3D HSC expansion.
Cytomatrix will be the most scalable solution.
Cytomatrix will be the best suited to an “off the shelf” approach.
Will incorporate the leading proven technology.
Faster path to regulatory approval because of existing clinical data